Similar articles

• Varicella vaccination: where do we go from here?

  Brunell PA. Brunell PA. Hosp Pract. 1980 Sep;15(9):91-3, 97, 100-1 passim. doi: 10.1080/21548331.1980.11946658. Hosp Pract. 1980. PMID: 6250972
• Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.

  Miller E, Cradock-Watson JE, Ridehalgh MK. Miller E, et al. Lancet. 1989 Aug 12;2(8659):371-3. doi: 10.1016/s0140-6736(89)90547-3. Lancet. 1989. PMID: 2569560
• Prevention or modification of varicella using zoster immune plasma.

  Balfour HH Jr, Groth KE, McCullough J, Kalis JM, Marker SC, Nesbit ME, Simmons RL, Najarian JS. Balfour HH Jr, et al. Am J Dis Child. 1977 Jun;131(6):693-6. doi: 10.1001/archpedi.1977.02120190087020. Am J Dis Child. 1977. PMID: 194476
• Humoral and cellular immunity to varicella-zoster virus: an overview.

  Arvin AM. Arvin AM. J Infect Dis. 2008 Mar 1;197 Suppl 2:S58-60. doi: 10.1086/522123. J Infect Dis. 2008. PMID: 18419410 Review. No abstract available.
• The future of varicella vaccine.

  Plotkin SA, Arbetter AA, Starr SE. Plotkin SA, et al. Postgrad Med J. 1985;61 Suppl 4:155-62. Postgrad Med J. 1985. PMID: 3014474 Review.